Of the three patients with cytoplasmic and two patients with subclonal abnormal p53 expression (in 60% and 75% of the tumor), the tumor recurred in one patient in both groups, resulting in overlapping survival curves (Supplementary Fig. S3A). This evidence concerns the gene TP53 and neoplasm.